Cyclic vs. Constant Estradiol: Regimens' Effects on Brain Health
Part of paid clinical trials in Aurora, Colorado.
- Sponsor
- University of Colorado, Denver
- Study ID
- NCT07831499
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Brain
- Healthy Adult
- Menopause
- Postmenopausal
Eligibility Criteria
- Sex
- FEMALE
- Age
- 38 Years - 60 Years
- Healthy Volunteers
- Accepted
Interventions
- Cyclic Estradiol — DRUGParticipants randomized to the cyclic estradiol group apply a transdermal estradiol patch delivering 100 mcg/day for 5 days every 21 days over approximately 12 weeks. The patch is removed on the fifth day of each treatment cycle. The final patch is worn for 7 days.
- Continuous Estradiol — DRUGParticipants randomized to the continuous estradiol group apply a transdermal estradiol patch delivering 100 mcg/day continuously for approximately 12 weeks. The patch is replaced every 6 days and worn throughout the treatment period. The final patch is worn for 7 days.
Study Details
The purpose of this study is to learn more about how estradiol patch treatment affects brain processes, health, and wellbeing.
Key Dates
- First listed
- Sep 21, 2026
- Start date
- Jul 15, 2026
- Status verified
- Sep 2026
- Primary completion
- Jul 15, 2028
- Completion
- Jul 15, 2028
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Cyclic EstradiolTransdermal estradiol 100 mcg/day patch applied for 5 days every 21 days for approximately 12 weeks.
- Experimental: Continuous EstradiolTransdermal estradiol 100 mcg/day patch worn continuously and replaced every 6 days for approximately 12 weeks.
Primary Outcome Measure
Change in Dorsolateral Prefrontal Cortex (dlPFC) activation during working memory task in women receiving either cyclic or continuous estradiol administration. [ Time Frame: Baseline and approximately 12 weeks after initiation of study treatment ]
Central Contacts
- Research Services Professional720-281-9282
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Colorado Anschutz | Aurora | Colorado | 80045 | Neill Epperson, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Aurora, CO
By condition
By specialty
By research site
Related Studies
- Bioenergetic Effects of Aging and Menopause (BEAM)PHASE4 · Recruiting · University of Colorado, Denver · Aurora, Colorado
- Cardiometabolic Consequences of the Loss of Ovarian FunctionPHASE4 · Recruiting · University of Colorado, Denver · Aurora, Colorado
- Menopausal HT for Women Living With HIV (HoT)PHASE4 · Recruiting · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections · Birmingham, Alabama
- Focusing on the Menopausal Transition to Improve Mid-Life Women's HealthPHASE2/PHASE3 · Recruiting · University of Colorado, Denver · Aurora, Colorado